IL-17A was positively correlated with the expression of PD-L1, which is in line with previous findings that IL-17A was found to induce cellular expression of PD-L1 in hepatocellular carcinoma stem cells, colorectal cancer, estrogen receptor-negative breast cancer, and cholangitis. This evidence concerns the gene CD274 and hepatocellular carcinoma.